These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 19952936)
21. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Vang R; Kempson RL Am J Surg Pathol; 2002 Jan; 26(1):1-13. PubMed ID: 11756764 [TBL] [Abstract][Full Text] [Related]
22. Myxoid mixed low-grade endometrial stromal sarcoma and smooth muscle tumor of the uterus. Case report. Dundr P; Fischerová D; Povýšil C; Cibula D; Zikán M Cesk Patol; 2012 Apr; 48(2):103-6. PubMed ID: 22716064 [TBL] [Abstract][Full Text] [Related]
23. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Amada S; Nakano H; Tsuneyoshi M Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525 [TBL] [Abstract][Full Text] [Related]
24. [Highly cellular leiomyoma of uterus: a comparative morphologic and immunohistochemical study of endometrial stromal tumors]. Liao X; Wang Y; Yue C; Liu Y; Wang H; Dai L; Hui Y Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):396-400. PubMed ID: 12485478 [TBL] [Abstract][Full Text] [Related]
25. Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases. Oliva E; Clement PB; Young RH; Scully RE Am J Surg Pathol; 1998 Aug; 22(8):997-1005. PubMed ID: 9706980 [TBL] [Abstract][Full Text] [Related]
26. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476 [TBL] [Abstract][Full Text] [Related]
27. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases. Dionigi A; Oliva E; Clement PB; Young RH Am J Surg Pathol; 2002 May; 26(5):567-81. PubMed ID: 11979087 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemistry as a diagnostic aid in the interpretation of unusual mesenchymal tumors of the uterus. Devaney K; Tavassoli FA Mod Pathol; 1991 Mar; 4(2):225-31. PubMed ID: 1710807 [TBL] [Abstract][Full Text] [Related]
29. The importance of CD10 and h-Caldesmon in the distinction of smooth muscle tumors of the uterus and endometrial stromal sarcoma. Saraydaroglu O; Ozuysal S; Kasap M; Ozerkan K Saudi Med J; 2008 Sep; 29(9):1349-50. PubMed ID: 18813428 [No Abstract] [Full Text] [Related]
30. The phosphatidylinositol 3' kinase-Akt-mammalian target of rapamycin pathway in smooth muscle tumors of the uterus: selected protein expression patterns and their clinicopathologic implications. Fadare O; Renshaw I; Olson SJ; Liang SX Int J Gynecol Pathol; 2011 May; 30(3):244-51. PubMed ID: 21464729 [TBL] [Abstract][Full Text] [Related]
31. Transgelin, a Novel Marker of Smooth Muscle Differentiation, Effectively Distinguishes Endometrial Stromal Tumors from Uterine Smooth Muscle Tumors. Tawfik O; Rao D; Nothnick WB; Graham A; Mau B; Fan F Int J Gynecol Obstet Reprod Med Res; 2014 Sep; 1(1):26-31. PubMed ID: 26023684 [TBL] [Abstract][Full Text] [Related]
32. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups. Bartosch C; Exposito MI; Lopes JM Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859 [TBL] [Abstract][Full Text] [Related]
33. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070 [TBL] [Abstract][Full Text] [Related]
35. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value. Petrović D; Babić D; Forko JI; Martinac I Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637 [TBL] [Abstract][Full Text] [Related]
36. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract. Riedlinger WF; Kozakewich HP; Vargas SO Pediatr Dev Pathol; 2005; 8(3):355-61. PubMed ID: 16010486 [TBL] [Abstract][Full Text] [Related]
37. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract. Riedlinger WF; Kozakewich HP; Vargas SO Pediatr Dev Pathol; 2005; 8(4):427-34. PubMed ID: 16220232 [TBL] [Abstract][Full Text] [Related]
38. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS). Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127 [TBL] [Abstract][Full Text] [Related]
39. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581 [TBL] [Abstract][Full Text] [Related]